These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7787967)

  • 1. Clinical evaluation of serum ornithine carbamoyltransferase by enzyme-linked immunosorbent assay in patients with liver diseases.
    Watanabe Y; Mori S; Fujiyama S; Sato T; Mori M
    Enzyme Protein; 1994-1995; 48(1):18-26. PubMed ID: 7787967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Ornithine Carbamoyltransferase in the Progression of Chronic Hepatitis C and Liver Cirrhosis.
    Ohnishi M; Higuchi A; Matsumura H; Arakawa Y; Nakamura H; Nirei K; Yamamoto T; Yamagami H; Ogawa M; Gotoda T; Matsuoka S; Nakajima N; Sugitani M; Moriyama M; Murayama H
    Int J Med Sci; 2017; 14(7):629-638. PubMed ID: 28824294
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation of ornithine carbamoyltransferase as a biomarker of liver cirrhosis.
    Matsushita N; Hashimoto E; Tokushige K; Kodama K; Tobari M; Kogiso T; Torii N; Taniai M; Shiratori K; Murayama H
    Intern Med; 2014; 53(12):1249-57. PubMed ID: 24930642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ratio of serum ornithine carbamoyltransferase to alanine aminotransferase as a potent indicator for hepatocellular carcinoma.
    Murayama H; Fukuda Y; Tsunekawa S; Ikemoto M; Nagata A
    Clin Biochem; 2007 Sep; 40(13-14):1077-80. PubMed ID: 17570354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
    Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
    Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive enzyme-linked immunosorbent assay of serum ornithine carbamoyltransferase.
    Watanabe Y; Mori S; Ozaki M; Fujiyama S; Sato T; Mori M
    Enzyme Protein; 1994-1995; 48(1):10-7. PubMed ID: 7787966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of the release of hepatic enzymes in various liver diseases. 1. Alterations in cytoplasmic and mitochondrial enzyme activities in serum.
    Miyake S
    Acta Med Okayama; 1979 Aug; 33(4):287-304. PubMed ID: 227231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of serum type-I arginase and ornithine carbamyltransferase in the detection of toxicant-induced acute hepatic injury in rats.
    Murayama H; Ikemoto M; Fukuda Y; Nagata A
    Clin Chim Acta; 2008 May; 391(1-2):31-5. PubMed ID: 18279670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of serum guanase activity in liver diseases.
    Nishikawa Y; Fukumoto K; Watanabe F
    Clin Biochem; 1984 Oct; 17(5):327-30. PubMed ID: 6499163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis.
    Williams AL; Hoofnagle JH
    Gastroenterology; 1988 Sep; 95(3):734-9. PubMed ID: 3135226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advantage of serum type-I arginase and ornithine carbamoyltransferase in the evaluation of acute and chronic liver damage induced by thioacetamide in rats.
    Murayama H; Ikemoto M; Fukuda Y; Tsunekawa S; Nagata A
    Clin Chim Acta; 2007 Jan; 375(1-2):63-8. PubMed ID: 16872590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate analysis of an enzymic profile for the differential diagnosis of viral hepatitis.
    Plomteux G
    Clin Chem; 1980 Dec; 26(13):1897-9. PubMed ID: 7438442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?
    Park GJ; Lin BP; Ngu MC; Jones DB; Katelaris PH
    J Gastroenterol Hepatol; 2000 Apr; 15(4):386-90. PubMed ID: 10824882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive ELISA for serum ornithine carbamoyltransferase utilizing the enhancement of immunoreactivity at alkaline pH.
    Murayama H; Igarashi M; Mori M; Fukuda Y; Ikemoto M; Nagata A
    Clin Chim Acta; 2006 Jun; 368(1-2):125-30. PubMed ID: 16445902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of postoperative acute kidney injury in patients with hepatocellular carcinoma.
    Xu J; Xia Y; Li S; Cheng X; Hu S; Gao Y; Zhou X; Wang G; Zheng Q
    Ann Clin Biochem; 2019 May; 56(3):357-366. PubMed ID: 30453754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diagnostic value of glutamic acid dehydrogenase].
    Rettenbacher-Däubner H; Rieder H; Sburny I
    Acta Hepatosplenol; 1967; 14(4):209-21. PubMed ID: 4297959
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical significance of serum guanase activity in various liver diseases.
    Shiota G; Fukada J; Ito T; Tsukizawa M; Yamada M; Sato M
    Jpn J Med; 1989; 28(1):22-4. PubMed ID: 2542677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome localized human hepatic alanine-glyoxylate aminotransferase and its application to clinical diagnosis.
    Nakatani T; Kawasaki Y; Minatogawa Y; Okuno E; Kido R
    Clin Biochem; 1985 Oct; 18(5):311-6. PubMed ID: 4053344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of pyridoxal phosphate and the transaminases in liver disease.
    Vanderlinde RE
    Ann Clin Lab Sci; 1986; 16(2):79-93. PubMed ID: 3008634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum level of ornithine carbamoyltransferase is influenced by the state of Kupffer cells.
    Murayama H; Ikemoto M; Fukuda Y; Tsunekawa S; Nagata A
    Clin Chim Acta; 2007 May; 380(1-2):170-4. PubMed ID: 17350606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.